These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3055567)
1. Development of malaria vaccines. Perrin LH; Simitsek P; Srivastava I Trop Geogr Med; 1988 Jul; 40(3):S6-21. PubMed ID: 3055567 [No Abstract] [Full Text] [Related]
2. [Immunology and molecular biology: targetting of a vaccine]. Perrin LH; Mach B Ther Umsch; 1986 Feb; 43(2):148-54. PubMed ID: 3515610 [No Abstract] [Full Text] [Related]
3. Development of asexual blood stage malaria vaccines. Kidson C Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):391-6. PubMed ID: 3064322 [No Abstract] [Full Text] [Related]
4. Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development. Cowman AF; Baldi DL; Duraisingh M; Healer J; Mills KE; O'Donnell RA; Thompson J; Triglia T; Wickham ME; Crabb BS Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):25-33. PubMed ID: 11839179 [TBL] [Abstract][Full Text] [Related]
5. Merozoite selection of erythrocytes by age and the induction of protective immunity. Brown KN; Carlsson J; Jarra W Blood Cells; 1990; 16(2-3):313-8. PubMed ID: 2096982 [No Abstract] [Full Text] [Related]
6. Vaccines for human malaria: epidemiological and immunological perspectives. Webster HK; Diggs CL; Ballou WR; Chulay JD Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):375-89. PubMed ID: 3064321 [No Abstract] [Full Text] [Related]
14. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum. Xu L; Pei X; Berzins K; Chaudhuri A Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297 [TBL] [Abstract][Full Text] [Related]
15. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity. Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301 [TBL] [Abstract][Full Text] [Related]
16. The immunological challenge to developing a vaccine to the blood stages of malaria parasites. Good MF; Stanisic D; Xu H; Elliott S; Wykes M Immunol Rev; 2004 Oct; 201():254-67. PubMed ID: 15361246 [TBL] [Abstract][Full Text] [Related]
17. Malaria vaccines - The long synthetic peptide approach: Technical and conceptual advancements. Olugbile S; Habel C; Servis C; Spertini F; Verdini A; Corradin G Curr Opin Mol Ther; 2010 Feb; 12(1):64-76. PubMed ID: 20140818 [TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum: analysis of the cytoadherence inhibition of the human monoclonal antibody 33G2 and of antibodies reactive with antigen Pf332. Iqbal J; Perlmann P; Berzins K Exp Parasitol; 1993 Aug; 77(1):79-87. PubMed ID: 8344409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]